These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37266828)

  • 1. Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator.
    Awad SS; Azeez EF; Taha MO; El-Naggar WM; El-Damaty A
    Egypt Heart J; 2023 Jun; 75(1):44. PubMed ID: 37266828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
    Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
    Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes.
    Fang Y; Gu K; Yang B; Ju W; Chen H; Li M; Liu H; Wang J; Yang G; Chen M
    J Arrhythm; 2018 Feb; 34(1):36-45. PubMed ID: 29721112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
    Grimm W; Plachta E; Maisch B
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
    Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients.
    Arenal A; Ortiz M; Peinado R; Merino JL; Quesada A; Atienza F; Alberola AG; Ormaetxe J; Castellanos E; Rodriguez JC; Pérez N; García J; Boluda L; del Prado M; Artés A
    Heart Rhythm; 2007 Mar; 4(3):316-22. PubMed ID: 17341396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.
    Kouakam C; Lauwerier B; Klug D; Jarwe M; Marquié C; Lacroix D; Kacet S
    Am J Cardiol; 2003 Jul; 92(1):26-32. PubMed ID: 12842240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal programming management of ventricular tachycardia storm in ICD patients.
    Qian Z; Guo J; Zhang Z; Wang Y; Hou X; Zou J
    J Biomed Res; 2015 Jan; 29(1):35-43. PubMed ID: 25745473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy.
    Tsukahara K; Oginosawa Y; Fujino Y; Honda T; Kikuchi K; Nozoe M; Uchida T; Minamiguchi H; Sonoda K; Ogawa M; Ideguchi T; Kizaki Y; Nakamura T; Oba K; Higa S; Yoshida K; Yagyu K; Miyamoto T; Yamagishi Y; Ohe H; Kohno R; Kataoka M; Otsuji Y; Abe H
    J Arrhythm; 2021 Aug; 37(4):1052-1060. PubMed ID: 34386132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. Multicenter PCD Investigator Group.
    Hammill SC; Packer DL; Stanton MS; Fetter J
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 1):3-10. PubMed ID: 7700828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients.
    Sharma V; DeGroot PJ; Wathen MS
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1156-62. PubMed ID: 14678127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging.
    Schoels W; Steinhaus D; Johnson WB; O'hara G; Schwab JO; Jenniskens I; Degroot PJ; Tang F; Helmling E;
    Heart Rhythm; 2007 Jul; 4(7):879-85. PubMed ID: 17599671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with a third-generation implantable cardioverter-defibrillator.
    Saksena S; Mehta D; Krol RB; Tullo NG; Saxena A; Kaushik R; Neglia J
    Am J Cardiol; 1991 Jun; 67(16):1375-84. PubMed ID: 2042568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.
    Wathen MS; Sweeney MO; DeGroot PJ; Stark AJ; Koehler JL; Chisner MB; Machado C; Adkisson WO;
    Circulation; 2001 Aug; 104(7):796-801. PubMed ID: 11502705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term efficacy of antitachycardia pacing for treatment of ventricular tachycardia in patients with implantable cardioverter/defibrillator].
    Fiek M; Hoffmann E; Dorwarth U; Müller D; Steinbeck G
    Z Kardiol; 1999 Oct; 88(10):815-22. PubMed ID: 10552185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease.
    Gillis AM; Leitch JW; Sheldon RS; Morillo CA; Wyse DG; Yee R; Klein GJ; Mitchell LB
    Am J Cardiol; 1993 Nov; 72(15):1146-51. PubMed ID: 8237804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of burst versus ramp antitachycardia pacing therapy for ventricular tachycardia: A meta-analysis.
    de Sousa MR; Cota GF; Burger AL; Pezawas T
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):842-850. PubMed ID: 33484214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.
    Wathen M
    Am Heart J; 2007 Apr; 153(4 Suppl):44-52. PubMed ID: 17394902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.